Graft-Versus-Host Disease - Epidemiology Forecast to 2023

EpiCast Report: Graft-Versus-Host Disease - Epidemiology Forecast to 2023 report provides an overview of the risk factors, comorbidities, and the global and historical trends for the diagnosed incidence of HSCTs (including first, multiple, and re-transplants), segmented by transplant type (autologous and allogeneic), and the diagnosed incidence of GVHD in diagnosed incident cases of first HSCTs in the six major markets (6MM) (US, France, Germany, Italy, Spain, and UK). Publisher epidemiologists also provide a forecast for the four-year diagnosed prevalent cases of aGVHD and the five-year diagnosed prevalent cases of cGVHD in the 6MM.